Solanbridge Financial Statements From 2010 to 2026
Solanbridge's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Solanbridge's valuation are provided below:Solanbridge Group does not presently have any fundamental trend indicators for analysis.
Check out the analysis of Solanbridge Correlation against competitors.
Check Solanbridge financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Solanbridge's main balance sheet or income statement drivers, such as , as well as many indicators such as . Solanbridge financial statements analysis is a perfect complement when working with Solanbridge Valuation or Volatility modules.
Solanbridge | Build AI portfolio with Solanbridge Stock |
Solanbridge Group Company Return On Asset Analysis
Solanbridge's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Solanbridge Return On Asset | -10.47 |
Most of Solanbridge's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Solanbridge Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Solanbridge Group has a Return On Asset of -10.4749. This is 19.71% higher than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Solanbridge Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Solanbridge's current stock value. Our valuation model uses many indicators to compare Solanbridge value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Solanbridge competition to find correlations between indicators driving Solanbridge's intrinsic value. More Info.Solanbridge Group is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Solanbridge's earnings, one of the primary drivers of an investment's value.About Solanbridge Financial Statements
Solanbridge investors use historical fundamental indicators, such as Solanbridge's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Solanbridge. Please read more on our technical analysis and fundamental analysis pages.
Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. The company was founded in 2000 and is headquartered in The Woodlands, Texas. SOLANBRIDGE GROUP operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Solanbridge Stock Analysis
When running Solanbridge's price analysis, check to measure Solanbridge's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solanbridge is operating at the current time. Most of Solanbridge's value examination focuses on studying past and present price action to predict the probability of Solanbridge's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solanbridge's price. Additionally, you may evaluate how the addition of Solanbridge to your portfolios can decrease your overall portfolio volatility.